A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study will determine how morbid obesity affects the distribution and metabolism of the
drug propofol. The investigators hypothesize that propofol will be distributed and
metabolized differently in morbidly obese subjects as compared to normal weight subjects.